Generate a tailored SOP for Dr. Anika Singanayagam. Improve your application with a focused, well-structured draft.
Anika Singanayagam is a Senior Clinical Research Fellow and Consultant Virologist at Imperial College London. She specializes in virology, particularly focusing on the transmission of respiratory viruses such as influenza and SARS-CoV-2. Her research aims to develop strategies to reduce viral transmission through testing, vaccines, and antivirals. Anika's current roles include Principal Investigator for the SARS-CoV-2 Delta variant human infection challenge study and co-investigator for the GERMINATE influenza H3N2 human infection challenge study. She leads a research package focused on surrogates of transmission within the MUSICC CEPI beta coronavirus human challenge consortium and is involved in pandemic preparedness studies, including household transmission studies. Anika graduated from Oxford University with a degree in Medicine and has completed an integrated clinical/academic training in Infectious Diseases. Her PhD research, under the Wellcome Trust Clinical Research Training Fellowship, investigated pandemic influenza viruses, contributing to public health policy by informing isolation strategies for SARS-CoV-2 infectiousness. Her work has provided crucial evidence on SARS-CoV-2 transmission among vaccinated individuals, significantly impacting global COVID-19 policies.
Specialisms available in Materials for the Energy Transition or Theory and Simulation of Materials.